ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "myositis and pediatric rheumatology"

  • Abstract Number: 390 • 2019 ACR/ARP Annual Meeting

    Preliminary Response to Janus Kinase (JAK) Inhibition with Baricitinib in Refractory Juvenile Dermatomyositis

    Hanna Kim1, Samantha Dill 2, Michelle O'Brien 2, Minal Jain 3, Shajia Lu 4, Wanxia Tsai 4, Yinghui Shi 5, Laura Vian 4, Massimo Gadina 4, Michelle Millwood 2, April Brundidge 2, Lisa G. Rider 6 and Robert Colbert 1, 1Pediatric Clinical Trials Unit, Pediatric Translational Research Branch, NIAMS, NIH, Bethesda, MD, 2Pediatric Clinical Trials Unit (PCTU), Office of the Clinical Director, NIAMS, NIH, Bethesda, MD, 3Rehabilitation Medicine Department, Physical Therapy Section, Clinical Research Center, NIH, Bethesda, MD, 4Translational Immunology Section, NIAMS, NIH, Bethesda, MD, 5Office of Clinical Director, NIAMS, NIH, Bethesda, MD, 6Environmental Autoimmunity Group, Clinical Research Branch, NIEHS, NIH, Bethesda, MD

    Background/Purpose: Juvenile dermatomyositis (JDM) is a systemic autoimmune disease with a prominent interferon (IFN) signature. Treatment often requires prolonged high-dose steroids and other immunosuppressive medications.…
  • Abstract Number: 282 • 2012 ACR/ARHP Annual Meeting

    Clinical and Laboratory Features Distinguishing Juvenile Polymyositis and Muscular Dystrophy in Children

    Gulnara Mamyrova1, James D. Katz1, Robert V. Jones2, Peter A. Lachenbruch3, Mona Shah3, Olcay Y. Jones1, Anupam Chahal1, Seema Agrawal1, Frederick W. Miller3, Lisa G. Rider3 and the Childhood Myositis Heterogeneity Group4, 1Rheumatology, George Washington University, Washington, DC, 2Pathology, George Washington University, Washington, DC, 3Environmental Autoimmunity Group, NIEHS, NIH, Bethesda, MD, 4Niehs, NIH, Bethesda, MD

    Background/Purpose: We examined demographic, clinical and laboratory features of juvenile polymyositis (JPM) and muscular dystrophy in children to improve classification of these two conditions. Methods:…
  • Abstract Number: 291 • 2012 ACR/ARHP Annual Meeting

    Illness Features Associated with an Increased Risk of Mortality in Children with Juvenile Idiopathic Inflammatory Myopathies

    Adam M. Huber1, Gulnara Mamyrova2, Julia A. Lee3, Peter A. Lachenbruch4, Ira N. Targoff5, Frederick W. Miller4, Lisa G. Rider4 and Childhood Myositis Heterogeneity Study Group6, 1Dalhousie University, Halifax, NS, Canada, 2Rheumatology, George Washington University, Washington, DC, 3Environmental Autoimmunity Grp, NIEHS, Bethesda, MD, 4Environmental Autoimmunity Group, NIEHS, NIH, Bethesda, MD, 5Arthritis and Immunology, Oklahoma Medical Research Foun, Oklahoma City, OK, 6Bethesda, MD

    Background/Purpose: Juvenile idiopathic inflammatory myopathies (JIIM) are potentially life-threatening systemic autoimmune diseases but little in known regarding factors associated with mortality. Methods: Patients enrolled in…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences